EOLS
Evolus Inc
NASDAQ: EOLS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.18
-1.71% today
Updated 2026-04-29
Market cap
$344.82M
P/E ratio
—
P/S ratio
1.16x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$4 – $12
Volume
1.1M
Evolus Inc (EOLS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $34.92M | $56.54M | $99.67M | $148.62M | $202.09M | $266.27M | $297.18M |
| Revenue growth (YoY) | — | — | — | — | — | +61.9% | +76.3% | +49.1% | +36.0% | +31.8% | +11.6% |
| Cost of revenue | $416000.00 | $326000.00 | $218000.00 | $0.00 | $8.01M | $18.30M | $43.53M | $58.84M | $61.56M | $83.97M | $104.41M |
| Gross profit | $-416000.00 | $-326000.00 | $-218000.00 | $0.00 | $26.91M | $38.24M | $56.14M | $89.77M | $140.53M | $182.30M | $192.76M |
| Gross margin | — | — | — | — | 77.1% | 67.6% | 56.3% | 60.4% | 69.5% | 68.5% | 64.9% |
| R&D | $20.68M | $12.61M | $6.69M | $6.49M | $3.97M | $1.72M | $2.06M | $6.74M | $15.43M | $9.17M | $9.58M |
| SG&A | $9.88M | $7.03M | $4.82M | $29.15M | $29.15M | $98.19M | $118.36M | $130.20M | $157.45M | $189.33M | $220.79M |
| Operating income | $-30.98M | $-19.97M | $-11.73M | $-46.14M | $-98.95M | $-153.07M | $-44.41M | $-65.33M | $-49.23M | $-34.41M | $-37.60M |
| Operating margin | — | — | — | — | -283.3% | -270.7% | -44.6% | -44.0% | -24.4% | -12.9% | -12.7% |
| EBITDA | $-30.56M | $-19.64M | $-11.51M | $-45.93M | $-92.10M | $-144.75M | $-39.06M | $-53.85M | $-41.81M | $-25.00M | $-28.86M |
| EBITDA margin | — | — | — | — | -263.7% | -256.0% | -39.2% | -36.2% | -20.7% | -9.4% | -9.7% |
| EBIT | $-30.98M | $-19.97M | $-11.73M | $-45.94M | $-97.11M | $-152.43M | $-45.37M | $-57.58M | $-47.68M | $-31.02M | $-37.60M |
| Interest expense | $0.00 | $0.00 | $0.00 | $863000.00 | $7.95M | $10.50M | $1.40M | $9.10M | $13.83M | $18.73M | $19.69M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-31.11M | $-20.07M | $-4.48M | $-46.87M | $-90.03M | $-163.01M | $-46.81M | $-74.41M | $-61.69M | $-50.42M | $-51.64M |
| Net income growth (YoY) | — | +35.5% | +77.7% | -946.1% | -92.1% | -81.1% | +71.3% | -59.0% | +17.1% | +18.3% | -2.4% |
| Profit margin | — | — | — | — | -257.8% | -288.3% | -47.0% | -50.1% | -30.5% | -18.9% | -17.4% |